Heart pump patients: aspirin may not be needed with blood thinner
NCT ID NCT07343102
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 220 advanced heart failure patients who received a CH-VAD heart pump to see if adding aspirin to the standard blood thinner warfarin changed their risk of serious bleeding or clotting events. The main goal was to compare survival without stroke, pump clots, major bleeding, or artery blockages over 12 months. Results help doctors decide the safest blood-thinning plan for these patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fuwai Hospital
Beijing, Beijing Municipality, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Dual-Chamber heart pump save the failing heart?
- Can a mechanical heart pump offer a lifeline for advanced heart failure?
- Heart-Kidney link under microscope in advanced heart failure study
- New heart pump offers hope for advanced heart failure patients
- Could LVAD patients ditch aspirin? new trial aims to find out
- Stem cell injection during bypass surgery aims to repair damaged hearts